Repligen Corp

RGEN XNAS BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Market Cap

6.8B

Short interest (May 15)

10.1%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.25%

↓ 8.5%

Available Shares

1M

↑ 86.7%

Price Chart

Company Overview

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Company Info

Exchange: NASDAQ
Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CIK: 0000730272
Asset Type: CS

Market Data

Market Cap: $6,832,669,546
Employees: 2,000
Status: Active

Short Interest

Current Borrow Fee 0.25%
Range: 0.25% - 0.26%
Available Shares 1M
Range: 1.3M - 1.3M

Recent Changes

Fee Change: ↓ 1.9%
Available Change: ↓ 3.9%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime